See Our Current Investments

CANCER THERAPEUTICS

articles with this tag

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

May 5, 2020

OncoSil Medical (ASX:OSL) has received CE Mark approval to market and sell its breakthrough implantable radiotherapy treatment for pancreatic cancer in the EU and UK.

Be the first to find out about our next investment.

Thanks for subscribing!

X